1
Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: January 17, 2013Recruiting
958 Clinical Trials for: Follicular Lymphoma, Page 1 of 48
Hide Studies Not Seeking New Volunteers
2
Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy
Condition(s): Follicular Lymphoma; Follicular Non-Hodgkin´s Lymphoma; Autologous Effector Lymphocytes Last Updated: June 22, 2012Recruiting
3
Idiotypic Vaccination for Follicular Lymphoma Patients
Condition(s): Follicular Lymphoma; First Relapse/Progression Last Updated: October 5, 2011Recruiting
4
Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia
Condition(s): Follicular Lymphoma; Chronic Lymphocytic Leukemia; Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular Last Updated: May 31, 2012Completed
5
Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: July 25, 2008Recruiting
6
High-Dose Therapy Treatment in Patients With Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: October 23, 2008Completed
7
Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
Condition(s): Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma Last Updated: April 11, 2013Not yet recruiting
8
Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma
Condition(s): Lymphoma, Follicular Last Updated: March 14, 2010Active, not recruiting
9
Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: July 19, 2011Recruiting
10
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
Condition(s): Lymphoma, Follicular Last Updated: November 30, 2010Active, not recruiting
11
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
Condition(s): Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma Last Updated: May 6, 2013Recruiting
12
Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: October 26, 2012Completed
13
Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: January 24, 2013Active, not recruiting
14
Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: December 16, 2012Active, not recruiting
15
VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma
Condition(s): Non Hodgkin's Follicular Lymphoma Last Updated: April 11, 2013Completed
16
Zevalin® First Line in Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: July 31, 2012Active, not recruiting
17
Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: December 3, 2012Completed
18
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Condition(s): Lymphoma Last Updated: June 29, 2010Not yet recruiting
19
Dietary Intervention in Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: May 20, 2008Recruiting
20
Trial of Low-Dose MTX and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
Condition(s): Follicular Lymphoma Last Updated: February 14, 2013Recruiting
